CardioMetabolic Care
An integrated approach
More about:
Merck Serono combines its drugs for treating diabetes, cardiovascular diseases and thyroid disorders in one therapeutic area:
CardioMetabolic Care. In recent years, interrelationships between cardiovascular diseases, diabetes and thyroid disorders
have been recognized and documented. Merck Serono offers doctors and patients the opportunity to treat the often complex symptoms
more effectively by taking an integrated approach to disease management.
Diabetes and heart disease are closely linked; studies show that diabetes is frequently combined with other cardiovascular
risk factors such as high blood pressure, obesity and lipid disorders, a clustering of risk factors known as metabolic syndrome.
Thyroid disorders are closely associated with both diabetes and cardiovascular disease. In patients with type 2 diabetes,
thyroid disorders are two-to-five times more frequent than among the general population. Heart muscle cells contain receptors
for thyroid hormones, so cardiac function is influenced by too many or too few thyroid hormones.
Cardiovascular diseases continue to be the most frequent cause of death in industrialized countries. Merck Serono offers an
extensive range of therapeutic options to treat these conditions, along with drugs for the treatment of glucose metabolism
and thyroid disorders. Merck Serono is among the leading manufacturers of oral antidiabetic agents for the treatment of type
2 diabetes, formerly referred to as “adult-onset diabetes”.
More about:
| Disclaimer |
|
This section gives an overview of our Company's activities in cardio-metabolic diseases. The information may refer to pharmaceutical products, therapeutics or indications not yet registered or approved in a given country. US Residents should consult the EMD Serono, Inc. for information on products approved for sale in the United States of America. |
